Akebia Therapeutics AKBA Q2 2025 earnings
Reported August 7, 2025 · Before market open
Revenue$62.5MBeat by $14.6M
EPS$0.00Beat by $0.02
Revenue estimate$47.9M
EPS estimate-$0.02
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$48.9M
EPS estimate-$0.03
Versus estimates
Revenue
Diluted EPS
Ask the moment Akebia Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Akebia Therapeutics report Q2 2025 earnings?
- Akebia Therapeutics (AKBA) reported Q2 2025 earnings on August 7, 2025 before market open.
- What were Akebia Therapeutics's Q2 2025 revenue and EPS?
- Akebia Therapeutics reported revenue of $62.5M and eps of $0.00 for Q2 2025.
- Did Akebia Therapeutics beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $47.9M by $14.6M. EPS beat the consensus estimate of $-0.02 by $0.02.
- How did Akebia Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 43.1% from $43.6M a year earlier.
- Where can I find Akebia Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001628280-25-038600) directly on SEC EDGAR. The filing index links above go to sec.gov.